Arginase 2 promotes neurovascular degeneration during ischemia/reperfusion injury

Esraa Shosha, Zhimin Xu, Harumasa Yokota, Alan B Saul, Modesto Antonio Rojas, Robert William Caldwell, Ruth B Caldwell, Subhadra Priyadarshini Narayanan

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Retinal ischemia is a major cause of visual impairment and blindness and is involved in various disorders including diabetic retinopathy, glaucoma, optic neuropathies and retinopathy of prematurity. Neurovascular degeneration is a common feature of these pathologies. Our lab has previously reported that the ureahydrolase arginase 2 (A2) is involved in ischemic retinopathies. Here, we are introducing A2 as a therapeutic target to prevent neurovascular injury after retinal ischemia/reperfusion (I/R) insult. Studies were performed with mice lacking both copies of A2 (A2− / − ) and wild-type (WT) controls (C57BL6J). I/R insult was conducted on the right eye and the left eye was used as control. Retinas were collected for analysis at different times (3 h–4 week after injury). Neuronal and microvascular degeneration were evaluated using NeuN staining and vascular digests, respectively. Glial activation was evaluated by glial fibrillary acidic protein expression. Necrotic cell death was studied by propidium iodide labeling and western blot for RIP-3. Arginase expression was determined by western blot and quantitative RT-PCR. Retinal function was determined by electroretinography (ERG). A2 mRNA and protein levels were increased in WT I/R. A2 deletion significantly reduced ganglion cell loss and microvascular degeneration and preserved retinal morphology after I/R. Glial activation, reactive oxygen species formation and cell death by necroptosis were significantly reduced by A2 deletion. ERG showed improved positive scotopic threshold response with A2 deletion. This study shows for the first time that neurovascular injury after retinal I/R is mediated through increased expression of A2. Deletion of A2 was found to be beneficial in reducing neurovascular degeneration after I/R.

Original languageEnglish (US)
Article numbere2483
JournalCell Death and Disease
Volume7
Issue number11
DOIs
StatePublished - Jan 1 2016

Fingerprint

Arginase
Reperfusion Injury
Ischemia
Reperfusion
Electroretinography
Neuroglia
Wounds and Injuries
Cell Death
Western Blotting
Optic Nerve Diseases
Retinopathy of Prematurity
Retinal Degeneration
Propidium
Glial Fibrillary Acidic Protein
Vision Disorders
Diabetic Retinopathy
Blindness
Ganglia
Glaucoma
Blood Vessels

ASJC Scopus subject areas

  • Immunology
  • Cellular and Molecular Neuroscience
  • Cell Biology
  • Cancer Research

Cite this

Arginase 2 promotes neurovascular degeneration during ischemia/reperfusion injury. / Shosha, Esraa; Xu, Zhimin; Yokota, Harumasa; Saul, Alan B; Rojas, Modesto Antonio; Caldwell, Robert William; Caldwell, Ruth B; Narayanan, Subhadra Priyadarshini.

In: Cell Death and Disease, Vol. 7, No. 11, e2483, 01.01.2016.

Research output: Contribution to journalArticle

@article{9c3b2747c6924fdeb3e11dbe5b3fb9a3,
title = "Arginase 2 promotes neurovascular degeneration during ischemia/reperfusion injury",
abstract = "Retinal ischemia is a major cause of visual impairment and blindness and is involved in various disorders including diabetic retinopathy, glaucoma, optic neuropathies and retinopathy of prematurity. Neurovascular degeneration is a common feature of these pathologies. Our lab has previously reported that the ureahydrolase arginase 2 (A2) is involved in ischemic retinopathies. Here, we are introducing A2 as a therapeutic target to prevent neurovascular injury after retinal ischemia/reperfusion (I/R) insult. Studies were performed with mice lacking both copies of A2 (A2− / − ) and wild-type (WT) controls (C57BL6J). I/R insult was conducted on the right eye and the left eye was used as control. Retinas were collected for analysis at different times (3 h–4 week after injury). Neuronal and microvascular degeneration were evaluated using NeuN staining and vascular digests, respectively. Glial activation was evaluated by glial fibrillary acidic protein expression. Necrotic cell death was studied by propidium iodide labeling and western blot for RIP-3. Arginase expression was determined by western blot and quantitative RT-PCR. Retinal function was determined by electroretinography (ERG). A2 mRNA and protein levels were increased in WT I/R. A2 deletion significantly reduced ganglion cell loss and microvascular degeneration and preserved retinal morphology after I/R. Glial activation, reactive oxygen species formation and cell death by necroptosis were significantly reduced by A2 deletion. ERG showed improved positive scotopic threshold response with A2 deletion. This study shows for the first time that neurovascular injury after retinal I/R is mediated through increased expression of A2. Deletion of A2 was found to be beneficial in reducing neurovascular degeneration after I/R.",
author = "Esraa Shosha and Zhimin Xu and Harumasa Yokota and Saul, {Alan B} and Rojas, {Modesto Antonio} and Caldwell, {Robert William} and Caldwell, {Ruth B} and Narayanan, {Subhadra Priyadarshini}",
year = "2016",
month = "1",
day = "1",
doi = "10.1038/cddis.2016.295",
language = "English (US)",
volume = "7",
journal = "Cell Death and Disease",
issn = "2041-4889",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Arginase 2 promotes neurovascular degeneration during ischemia/reperfusion injury

AU - Shosha, Esraa

AU - Xu, Zhimin

AU - Yokota, Harumasa

AU - Saul, Alan B

AU - Rojas, Modesto Antonio

AU - Caldwell, Robert William

AU - Caldwell, Ruth B

AU - Narayanan, Subhadra Priyadarshini

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Retinal ischemia is a major cause of visual impairment and blindness and is involved in various disorders including diabetic retinopathy, glaucoma, optic neuropathies and retinopathy of prematurity. Neurovascular degeneration is a common feature of these pathologies. Our lab has previously reported that the ureahydrolase arginase 2 (A2) is involved in ischemic retinopathies. Here, we are introducing A2 as a therapeutic target to prevent neurovascular injury after retinal ischemia/reperfusion (I/R) insult. Studies were performed with mice lacking both copies of A2 (A2− / − ) and wild-type (WT) controls (C57BL6J). I/R insult was conducted on the right eye and the left eye was used as control. Retinas were collected for analysis at different times (3 h–4 week after injury). Neuronal and microvascular degeneration were evaluated using NeuN staining and vascular digests, respectively. Glial activation was evaluated by glial fibrillary acidic protein expression. Necrotic cell death was studied by propidium iodide labeling and western blot for RIP-3. Arginase expression was determined by western blot and quantitative RT-PCR. Retinal function was determined by electroretinography (ERG). A2 mRNA and protein levels were increased in WT I/R. A2 deletion significantly reduced ganglion cell loss and microvascular degeneration and preserved retinal morphology after I/R. Glial activation, reactive oxygen species formation and cell death by necroptosis were significantly reduced by A2 deletion. ERG showed improved positive scotopic threshold response with A2 deletion. This study shows for the first time that neurovascular injury after retinal I/R is mediated through increased expression of A2. Deletion of A2 was found to be beneficial in reducing neurovascular degeneration after I/R.

AB - Retinal ischemia is a major cause of visual impairment and blindness and is involved in various disorders including diabetic retinopathy, glaucoma, optic neuropathies and retinopathy of prematurity. Neurovascular degeneration is a common feature of these pathologies. Our lab has previously reported that the ureahydrolase arginase 2 (A2) is involved in ischemic retinopathies. Here, we are introducing A2 as a therapeutic target to prevent neurovascular injury after retinal ischemia/reperfusion (I/R) insult. Studies were performed with mice lacking both copies of A2 (A2− / − ) and wild-type (WT) controls (C57BL6J). I/R insult was conducted on the right eye and the left eye was used as control. Retinas were collected for analysis at different times (3 h–4 week after injury). Neuronal and microvascular degeneration were evaluated using NeuN staining and vascular digests, respectively. Glial activation was evaluated by glial fibrillary acidic protein expression. Necrotic cell death was studied by propidium iodide labeling and western blot for RIP-3. Arginase expression was determined by western blot and quantitative RT-PCR. Retinal function was determined by electroretinography (ERG). A2 mRNA and protein levels were increased in WT I/R. A2 deletion significantly reduced ganglion cell loss and microvascular degeneration and preserved retinal morphology after I/R. Glial activation, reactive oxygen species formation and cell death by necroptosis were significantly reduced by A2 deletion. ERG showed improved positive scotopic threshold response with A2 deletion. This study shows for the first time that neurovascular injury after retinal I/R is mediated through increased expression of A2. Deletion of A2 was found to be beneficial in reducing neurovascular degeneration after I/R.

UR - http://www.scopus.com/inward/record.url?scp=85028689546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028689546&partnerID=8YFLogxK

U2 - 10.1038/cddis.2016.295

DO - 10.1038/cddis.2016.295

M3 - Article

C2 - 27882947

AN - SCOPUS:85028689546

VL - 7

JO - Cell Death and Disease

JF - Cell Death and Disease

SN - 2041-4889

IS - 11

M1 - e2483

ER -